Results 221 to 230 of about 9,354,751 (270)

Hepatic Candidiasis Following Drug-Induced Neutropenia in ANCA-Associated Vasculitis: A Diagnostic Challenge. [PDF]

ACG Case Rep J
Park JH, Kumar R, Vikash F, Kumar S, Nankani A, Kajal D, Radulovic M, Patel S.   +7 more
europepmc   +1 more source

Values, preferences, and informational needs of individuals living with ANCA-associated vasculitis: a systematic review. [PDF]

Rheumatol Adv Pract
Junek M, Choi S, Qi Y, Al-Magooshi ASA, Guyatt G, Thabane L, Mendel A, Khalidi N, Walsh M.   +8 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Treatment of ANCA-Associated Vasculitis

New England Journal of Medicine, 2003
Vasculitis is defined by inflammation of the blood-vessel wall and forms the pathological foundation of a diverse group of individual disease entities. Among the primary systemic vasculitic diseases, Wegener's granulomatosis and microscopic polyangiitis share several common features, including pulmonary capillaritis, pauci-immune focal crescentic ...
Carol A Langford
exaly   +3 more sources

ANCA-Associated Vasculitis: Core Curriculum 2020.

American Journal of Kidney Diseases, 2020
Antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) is a group of disorders characterized by inflammation and destruction of small- and medium-sized blood vessels and the presence of circulating ANCA.
D. Geetha, J. Jefferson
semanticscholar   +1 more source

Biologics for ANCA-Associated Vasculitis

Inflammation & Allergy-Drug Targets, 2014
The antineutrophil cytoplasmic antibody (ANCA)-associated vasculitides (AAV) are a group of necrotizing vasculitides with a potential fatal outcome. Conventional therapy is based on the use of glucocorticoids (GCs) and cyclophosphamide (CYC), which is associated with severe toxic effects and is unable to control the disease activity in some refractory ...
Murgia G, FIRINU, DAVIDE, MANCONI, PAOLO EMILIO, DEL GIACCO, STEFANO   +3 more
openaire   +3 more sources

Management of ANCA associated vasculitis

BMJ, 2020
ABSTRACTAnti-neutrophil cytoplasmic antibody (ANCA) associated vasculitis (AAV) is a small to medium vessel vasculitis associated with excess morbidity and mortality. This review explores how management of AAV has evolved over the past two decades with pivotal randomized controlled trials shaping the management of induction and maintenance of remission.
Zachary S, Wallace, Eli M, Miloslavsky
openaire   +2 more sources

Pathophysiology of ANCA-associated Vasculitis

Advances in Anatomic Pathology, 2017
Antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis is characterized as inflammation of small-sized to medium-sized blood vessels and encompasses several clinicopathologic entities including granulomatosis with polyangiitis, microscopic polyangiitis, eosinophilic granulomatosis with polyangiitis, and renal-limited ANCA-associated ...
Turki, Al-Hussain, Maged H, Hussein, Walter, Conca, Hadeel, Al Mana, Mohammed, Akhtar   +4 more
openaire   +2 more sources

ANCA-ASSOCIATED VASCULITIS

Acta Clinica Belgica, 2013
info:eu-repo/semantics ...
openaire   +3 more sources